Chiropractor Sentenced to 43 Months in Prison for $14.9 Million Health Care Fraud and Kickback Scheme Related to Durable Medical Equipment and Cancer Genetic Testing

NEWARK, N.J. – A Georgia chiropractor was sentenced to 43 months in prison for her role in a $14.9 million health care fraud and illegal kickback conspiracy, Senior Counsel Philip Lamparello announced. “This defendant built a business model around fraud—using kickbacks, sham arrangements, and medically unnecessary equipment to siphon millions from Medicare. Health care programs exist to serve patients, not to bankroll schemes like this one. Today’s sentence holds her accountable and underscores that those who abuse our federal health care system for profit will face serious consequences.” - Senior Counsel Philip Lamparello Teflyon Cameron, 59, of Powder Springs, Georgia, previously pleaded guilty before U.S. District Judge Michael E. Farbiarz on March 2, 2026, in Newark federal court to an Information charging her with conspiracy to commit health care fraud and conspiracy to violate the Federal Anti-Kickback statute According to documents filed in this case and statements made in court: For several years, Cameron conspired to defraud health insurers, including Medicare, by causing the submission of claims for medically unnecessary Durable Medical Equipment (DME) and Cancer Genetic Tests (CGx). In total, Cameron and her conspirators caused a loss to Medicare of more than $14.9 million, and Cameron pocketed more than $1.3 million in fraud proceeds. Cameron and her conspirators owned, operated, and had a financial interest in DME companies through which they obtained doctors’ orders for durable medical equipment, namely orthotic braces, for Medicare beneficiaries without regard to medical necessity. Cameron and her conspirators obtained DME orders using marketing call centers and telemedicine companies, caused the submission of false and fraudulent claims to Medicare, and paid illegal kickbacks. Cameron and her conspirators also owned, operated, and had a financial interest in a CGx company through which she agreed to provide a clinical laboratory with leads of beneficiaries who were qualified to receive federal health care benefits for cancer genetic tests. Cameron submitted invoices to the clinical laboratory seeking payment on a per-lead basis, but entered into a sham agreement to disguise kickback and bribe payments.